Access Genetics dba OralDNA® Labs acquires Breakthrough Point-of-Care Rapid PCR Technology from Sensible Diagnostics Inc.
Acquiring Company
OralDNA® Labs
Acquired Company
Sensible Diagnostics
Eden PrairieSan DimasBiotechnologyHealth CareBiotechnologyHealth CareHealth DiagnosticsDescription
Access Genetics dba OralDNA® Labs proudly announces the acquisition of Sensible Diagnostics Inc., and the assets of their patent-pending real-time quantitative PCR testing platform. With this acquisition, Access Genetics dba OralDNA® Labs aims to commercialize a new standard in point-of-care molecular diagnostics, offering speed and affordability, reinforcing their commitment to innovation in healthcare diagnostics.
Quick answer
OralDNA® Labs is acquiring Sensible Diagnostics, announced October 22, 2024. OralDNA® Labs is based in Eden Prairie, Minnesota, United States.
- How much did OralDNA® Labs pay for Sensible Diagnostics?
- The deal value was not disclosed.
- What does OralDNA® Labs do?
- Access Genetics dba OralDNA® Labs is a leader in salivary diagnostics, offering a comprehensive menu of infectious and human genetic markers.
- Where are OralDNA® Labs and Sensible Diagnostics based?
- OralDNA® Labs is based in Eden Prairie, Minnesota, United States. Sensible Diagnostics is based in San Dimas, California, United States.
- Who are the decision-makers at OralDNA® Labs?
- Fundz holds 1 contact at OralDNA® Labs. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Health Diagnostics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- LabGenomics USA Completes Acquisition of IMD CLIA Labs to Expand Diagnostic Services (October 25, 2024)
- XOMA Royalty Corporation acquires Pulmokine Inc. for $20 Million to add Seralutinib, a Phase 3 Asset, to its Portfolio, $20M (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Novartis acquires Kate Therapeutics to strengthen gene therapy portfolio (November 21, 2024)
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
Who to call at OralDNA® Labs, and when
When OralDNA® Labs changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day OralDNA® Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OralDNA® Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OralDNA® Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OralDNA® Labs makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sensible Diagnostics?
Sensible Diagnostics was acquired by OralDNA® Labs, based in Eden Prairie. The deal was reported on October 22, 2024. Access Genetics dba OralDNA® Labs is a leader in salivary diagnostics, offering a comprehensive menu of infectious and human genetic markers. OralDNA® Labs is privately held and operates in Biotechnology.
When did OralDNA® Labs acquire Sensible Diagnostics?
OralDNA® Labs's acquisition of Sensible Diagnostics was reported on October 22, 2024. Access Genetics dba OralDNA® Labs proudly announces the acquisition of Sensible Diagnostics Inc., and the assets of their patent-pending real-time quantitative PCR testing platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sensible Diagnostics do?
Sensible Diagnostics Inc. is the developer of a patent-pending state-of-the-art platform for real-time quantitative PCR testing. It is privately held, operating in Biotechnology, and is based in San Dimas.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.